Accent Group Limited (ASX:AX1) Releases FY25 Trading Update
Accent Group Limited (ASX:AX1) releases H2 trading update, forecasting FY25 EBIT of $108-111m amid challenging market conditions.
Accent Group Limited (ASX:AX1) releases H2 trading update, forecasting FY25 EBIT of $108-111m amid challenging market conditions.
Challenger Limited (ASX:CGF) supports APRA’s new capital settings for annuities, enhancing Australia’s retirement income market.
ASX Limited (ASX:ASX) completes the sale of its stake in Digital Asset Holdings for $57 million, recognising a pre-tax gain of $42 million in FY25.
ASX Limited (ASX:ASX) announces its Investor Forum 2025, detailing progress on its five-year strategy and providing financial guidance.
Tower Limited (ASX:TWR) appoints Paul Johnston as permanent CEO and initiates search for a new CFO, ensuring leadership continuity.
ARC Funds Limited (ASX:ARC) plans to acquire the remaining 36.51% shares in TTDS through a scrip offer, enhancing its growth strategy and FUM.
Articore Group Limited (ASX:ATG) reaffirms its FY25 guidance and initiates a strategic review to enhance shareholder value and accelerate growth.
Zip Co Limited (ASX:ZIP) upgrades FY25 guidance to $160m cash EBTDA, citing strong May performance and US TTV growth above 40%.
Centrex Limited (ASX:CXM) reconvenes its second creditors meeting, proposing a DOCA by PRL Global Limited.
Botanix Pharmaceuticals (ASX:BOT) secures A$48 million debt facility with Kreos Capital to support Sofdra™ commercialisation and platform expansion.